Tvardi Therapeutics Inc (TVRD)

$26.54 +0.54 (2.08%)
Market Cap 39.63M
Revenue (ttm) 7.14M
Net Income (ttm) -70.87M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -992.58%
Debt to Equity Ratio 0.00
Volume 24,900
Avg Vol 18,767
Day's Range N/A - N/A
Shares Out 1.52M
Stochastic %K 66%
Beta 0.21
Analysts Strong Sell
Price Target $39.00

Latest News on TVRD

Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update

May 13, 2025, 4:05 PM EDT - 17 hours ago

Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update

Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference

May 6, 2025, 7:00 AM EDT - 8 days ago

Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics

Apr 15, 2025, 4:05 PM EDT - 4 weeks ago

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics

CARA